The Food and Drug Administration approved the weight loss drug Wegovy to treat an increasingly prevalent liver disease on ...

This September, Michter's will release its US*1 Toasted Barrel Finish Sour Mash Whiskey. This whiskey is part of Michter's ...

The glucagon-like peptide-1 (GLP-1) receptor agonist gained accelerated approval for patients with MASH and moderate to ...

Soup and beer fans are getting a new mash-up this fall. Campbell’s Chunky is partnering with Pabst Blue Ribbon to launch two ...

Potatoes are the unsung stars of Indian kitchens. Easy to cook, endlessly versatile, and comforting in every form, they ...

Uncle Nearest claimed four Golds at the 2025 BTI Tennessee Whiskey Judging, but Costco’s Kirkland bottling shown, offering ...

Old Forester Birthday Bourbon remains one of American whiskey’s most sought-after bottles, and for nearly 25 years, it has ...

The FDA has granted accelerated approval to semaglutide (Wegovy; Novo Nordisk) injection 2.4 mg for the treatment of adults with metabolic dysfunction–associated steatohepatitis (MASH) with moderate ...

The approval was based on Part 1 (72 week data) of the randomized, double-blind, placebo-controlled phase 3 ESSENCE trial.

Viking Therapeutics, Inc.'s VK2735 trial results disappointed, yet long-term potential in the obesity market makes the stock ...

Originally established by Robert Cooke in East London, F. Cooke is the oldest established eel and pie house family still in ...

Pemvidutide is the only drug currently granted Fast Track Designation in AUD ...